Early Access — free while we kick the tires
EdgarHawk

Rahilly Sean

General Counsel and Secretary

Officer
4 filings analyzed · 1 company · Latest 2026-02-03

Companies

Company Buys Sells Direction
Enova International, Inc. ENVA 0 8 Net selling

Activity

February 2026
medium
Sell
12,879 shares
$2,115,789
Significance 5/10

General Counsel Rahilly sold 12,879 shares of ENVA at $164.28 for $2.1M, retaining 100,877 shares post-sale.

Rahilly sold 12,879 shares (11.3% reduction in holdings) at $164.28 on 2026-01-30, generating $2,115,789.17. At his prior five sales at ENVA, post-sale 90-day returns averaged +5.8%, with zero instances of negative returns; this pattern indicates his prior sales have consistently preceded price appreciation, not declines. The current stock price of $159.07 sits 7.7% below the 52-week high of $172.37, though up 24.3% over 90 days. Enova's fundamentals remain solid: FY revenue growth of +25.5%, net income of $80,314,000, and a P/E of 13.46. Without a 10b5-1 plan FLAG or scheduled-transaction indicator, this discretionary sale occurs in the context of strong recent momentum and historically poorly-timed sales by this insider at this ticker—suggesting the stock may continue appreciating post-transaction.

May 2025
medium
Sell
9,046 shares
$859,855
Significance 5/10

General Counsel Rahilly sells 9,046 ENVA shares at $95.05; holds 103.8K post-sale.

Rahilly Sean, General Counsel and Secretary of Enova International, sold 9,046 shares (9.0K shares) at $95.05 on 2025-05-05 for $859,854.87, reducing his holdings from 112,888 to 103,842 shares. The sale occurred when ENVA traded at $95.05, which is 21.2% below its 52-week high of $116.49 and represents a 30-day gain of +5.4% but a 90-day decline of -21.2%. His prior four open-market sells at ENVA (all in 2024) showed mixed timing outcomes: all four generated positive 90-day returns (ranging from +1.4% to +11.5%), meaning the stock rose after each sale—a pattern of poorly-timed exits. The broader cross-ticker track record shows only 4 prior sells with a 0.00% well-timed rate and average 90-day return of +5.8%, indicating a consistent pattern of selling before subsequent gains. The company fundamentals remain solid (P/E of 9.96, $745.5M quarterly revenue, +25.5% annual revenue growth), providing no obvious red flag explanation for the sale.

November 2024
low
Sell
8,000 shares
$823,871
Significance 4/10

Enova General Counsel Rahilly sells 8,000 ENVA shares at $102.98; stock near 52-week high, up +20.0% in 30 days

Rahilly Sean, Enova's General Counsel and Secretary, sold 8,000 shares at $102.98 on 2024-11-11, reducing his holdings from 109,949 to 101,949 shares. The sale occurred near the stock's 52-week high of $103.90, following a strong +20.0% 30-day run and +24.9% 90-day advance. At the company level, fundamentals remain solid with annual revenue growth of +22.0% and a P/E of 14.93. However, Rahilly's historical pattern at this ticker offers little signal: across his 3 prior trades at ENVA, all were sells, and none achieved well-timed outcomes—post-sale 90-day returns were uniformly positive (+5.6%, +5.0%, +1.4%), meaning the stock continued rising after each sale. The current sale follows the same pattern and provides no clear timing or conviction signal relative to price momentum or company fundamentals.

July 2024
medium
Sell
10,158 shares
$826,505
Significance 4/10

Sean Rahilly (General Counsel) sold 10,158 shares of ENVA at $81.36 on 2024-07-26; stock now at $85.72.

Rahilly sold 10,158 shares (-9.1% of his pre-transaction holdings of 112.1K shares) at $81.36, just before ENVA rallied 37.7% over the following 30 days and 40.4% over 90 days to reach the current $85.72 price. His prior trades at ENVA have similarly underperformed: a 2024-02-20 sell returned +5.0% in 30 days but +1.6% in 90 days, and a 2024-02-16 sell returned -1.1% in 30 days but +1.4% in 90 days, establishing a 0% well-timed rate on this ticker. The company's fundamentals remain solid with revenue of $628.4M (annual growth +22.0%), net income of $53.9M, and a P/E of 12.68, offering little indication of deteriorating operational health that would justify the sale timing. The pattern across his ENVA transactions suggests a consistent lag in execution relative to subsequent price appreciation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access